MedPath

Study to Determine the Effects of Testosterone Replacement Therapy in Aging Men With Androgen Deficiency

Phase 2
Completed
Conditions
Men With Low Testosterone Levels
Interventions
Registration Number
NCT00161304
Lead Sponsor
Leonard S. Marks, M.D.
Brief Summary

The T-001 study is a placebo-controlled investigation of the effects of injectable testosterone replacement therapy on prostate tissues of aging men with low testosterone levels.

Detailed Description

The T-001 study is a placebo-controlled investigation of the effects of injectable testosterone replacement therapy on prostate tissues of aging men with low testosterone levels. The primary objectives of the study are to measure the changes in tissue hormones and other biomarkers in the prostate tissue specimens.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
44
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PlaceboPlaceboPlacebo
Testosterone EnanthateTestosterone EnanthateTestosterone
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Urological Sciences Research Foundation

🇺🇸

Culver City, California, United States

© Copyright 2025. All Rights Reserved by MedPath